According to a new report, published by KBV research, The Global Medical Aesthetics Market size is expected to reach $31.1 billion by 2030, rising at a market growth of 10.4% CAGR during the forecast period.
The Beauty Centers segment is experiencing a CAGR of 10.9% during (2023 - 2030). Beauty centers offer a unique blend of medical and spa-like atmospheres, making them appealing to a wide range of clients. Clients can enjoy the comfort and luxury of a spa while receiving medically supervised treatments. Many beauty centers specialize in non-invasive or minimally invasive aesthetic treatments, such as injectables (Botox, dermal fillers), laser therapy, chemical peels, and microdermabrasion. Beauty centers provide thorough consultations, educating clients about available treatments, expected outcomes, and potential risks.
The Non-Surgical Procedures segment is generating the highest revenue in the Global Medical Aesthetics Market by Procedure in 2022; thereby, achieving a market value of $20.5 billion by 2030. Dermal fillers like hyaluronic acid and collagen-based fillers are commonly used to reduce wrinkles, restore volume, and enhance facial features. They provide immediate results with minimal recovery time. Botulinum toxin injections, such as Botox, are used to relax facial muscles, reducing the appearance of wrinkles and fine lines. This treatment is minimally invasive and offers quick results.
The Body Contouring Devices segment would experience a CAGR of 12% during (2023 - 2030). Body contouring devices are designed to reshape and sculpt the body by reducing localized fat deposits, tightening skin, and improving overall body aesthetics. Body contouring devices can target various body areas, including the abdomen, thighs, buttocks, arms, and chin. This versatility allows practitioners to offer comprehensive body contouring solutions tailored to individual patient needs.
The North America region is registering maximum revenue in the Global Medical Aesthetics Market by Region in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $10.9 billion by 2030. The Europe region is anticipated to grow at a CAGR of 10% during (2023 - 2030). Additionally, The Asia Pacific region would witness a CAGR of 11.4% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/medical-aesthetics-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Allergan PLC (AbbVie, Inc.), Alma Lasers Ltd. (Sisram Medical Ltd.), Bausch Health Companies Inc, Anika Therapeutics, Inc, Johnson & Johnson, Merz Pharma GmbH & Co. KGaA, Candela corporation, Lumenis Be Ltd., Galderma S.A., and Cutera, Inc.
By End User
By Procedure
By Product
By Geography
Companies Profiled
Unique Offerings 
